Videos From ACC.19
Watch video coverage of the hottest ACC.19 trials.
This page features scientific coverage from ACC.19 including Expert Analyses, Summary Slides and visual abstracts of the hottest late-breaking clinical trials. This post-meeting content is meant to reinforce the teaching points and education presented during ACC.19 presented by the ACC.org Clinical Topic Collections. Click on each topic to view all of the related content. Stay tuned as additional content will be added in the coming weeks.
Patient Case Quiz: DAPT Strategies in ACS |
Summary Slide: COACT |
Summary Slide: AUGUSTUS |
Visual Abstract: AUGUSTUS |
Visual Abstract: REDUCE-IT Total Events |
Summary Slide: SMART-CHOICE |
Summary Slide: SAFARI-STEMI |
Summary Slide: STOPDAPT-2 |
Expert Analysis: Noninvasive Cardiac Radioablation for Ventricular Tachycardia: Lessons Learned and Future Directions |
Visual Abstract: WRAP-IT |
Summary Slide: Alcohol-AF |
Summary Slide: WRAP-IT |
Summary Slide: AUGUSTUS |
Visual Abstract: AUGUSTUS |
Expert Analysis: Antithrombotic Strategy in Patients with Atrial Fibrillation and Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention: Primary Results of the AUGUSTUS Trial |
A five-part surgeon's perspective series on major trials from ACC.19 |
Expert Analysis: A Heart Team Approach to ACC.19: Surgeon's Perspectives on Major ACC.19 Trials |
Expert Analysis: International Outcomes with Acute Aortic Dissection: Progress and Opportunity (IRAD) |
Visual Abstract: COAPT-QoL |
Expert Analysis: Assessing Efficacy of the MitraClip: Echocardiographic Outcomes (COAPT) |
Expert Analysis: The Low Risk TAVR Trials at ACC.19: Will TAVR replace SAVR for Aortic Stenosis (Evolut Low Risk: From a surgeon's perspective) |
Expert Analysis: TAVR for bicuspid aortic valves: Is surgery still the gold-standard? (PARTNER 3) |
Visual Abstract: PARTNER 3 |
Summary Slide: PARTNER 3 |
Expert Analysis: Will the Heartmate 3 Left ventricular Assist Device Gain Momentum with New Study Results? (MOMENTUM 3) |
Summary Slide: MOMENTUM 3 |
Visual Abstract: REDUCE-IT Total Events |
Expert Analysis: REDUCE-IT Update: No One Hit Wonder: High-Dose EPA Reduces Total Ischemic Events |
Summary Slide: CLEAR Wisdom |
Expert Analysis: Bempedoic Acid, the Next LDL Cholesterol-Lowering Medication to Join the Arsenal? Insights From the CLEAR Wisdom Trial |
Visual Abstract: Evolut Low Risk |
Summary Slide: Evolut Low Risk |
Visual Abstract: PARTNER 3 |
Summary Slide: PARTNER 3 |
Summary Slide: SMART-CHOICE |
Summary Slide: SAFARI-STEMI |
Expert Analysis: Important Interventional Trials from ACC.19 |
Visual Abstract: COAPT-QoL |
Visual Abstract: REDUCE-IT Total Events |
Summary Slide: CLEAR Wisdom |
Summary Slide: CREOLE |
Summary Slide: INFINITY |
Expert Analysis: "It's Not You, It's Me" - Is it Time to Break Up With Aspirin? |
Expert Analysis: Primary Prevention of Cardiovascular Disease in Individuals With Type 2 Diabetes: Time for Cardiology to Get Back in the Game |
Expert Analysis: ACC.19: Sports Cardiology Highlights |
Expert Analysis: ACC.19: Trials on Valvular Heart Disease |
Visual Abstract: Evolut Low Risk |
Summary Slide: Evolut Low Risk |
Visual Abstract: COAPT-QoL |
Visual Abstract: PARTNER 3 |
Summary Slide: PARTNER 3 |